Corey P. Mallett

This study evaluates an intranasal influenza vaccine based on neuraminidase (NA) adjuvanted with bacterial membrane-derived components, showing improved immunogenicity and protection against H5N1 challenge.

This study designs stem-epitope mimetics using computational methods to elicit broadly reactive antibodies against influenza viruses.

This paper designs chimeric influenza hemagglutinins that combine antigenic surfaces from different strains to elicit cross-group immunity and neutralize multiple strains.